Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection

Unknown

Open source

DOI
10.1056/evidoa2200302
Published
2023-02-28
Container
NEJM Evidence
Publisher
Massachusetts Medical Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2200302,
  title = {Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection},
  author = {Unknown},
  year = {2023},
  journal = {NEJM Evidence},
  doi = {10.1056/evidoa2200302},
  url = {https://doi.org/10.1056/evidoa2200302}
}

RIS

TY  - JOUR
TI  - Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection
AU  - Unknown
PY  - 2023
JO  - NEJM Evidence
DO  - 10.1056/evidoa2200302
UR  - https://doi.org/10.1056/evidoa2200302
ER  - 

APA

Unknown (2023). Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evidence. https://doi.org/10.1056/evidoa2200302

Source records